Atea Pharmaceuticals
AVIR
AVIR
133 hedge funds and large institutions have $213M invested in Atea Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 130 → 133 (+3)
8% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 39
0.27% more ownership
Funds ownership: 68.14% → 68.4% (+0.27%)
Holders
133
Holding in Top 10
2
Calls
$341K
Puts
$247K
Top Buyers
| 1 | +$8.37M | |
| 2 | +$7.58M | |
| 3 | +$3.04M | |
| 4 |
Renaissance Technologies
New York
|
+$2.38M |
| 5 |
Two Sigma Investments
New York
|
+$656K |
Top Sellers
| 1 | -$11.5M | |
| 2 | -$5.34M | |
| 3 | -$1.25M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.24M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$959K |